A life science delegation from the North of England is heading to BIO in San Francisco this week - the first time the region’s sector has worked together to promote its offer on the global stage.
The BIO International Convention (BIO) starts today and attracts over 15,000 biotechnology and pharma leaders. This event covers a wide spectrum of life science and application areas including drug discovery, bio-manufacturing, genomics, biofuels, nanotechnology and cell therapy.
The Northern Powerhouse life science delegation will promote the North of England as an attractive and competitive centre for international businesses to set up operations here for research, development and manufacturing.
The line-up is led by Alderley Park, one of the five major assets within Manchester Science Partnerships - a portfolio that also includes a sci-tech Central Campus in Manchester.
The delegation also features Redx Pharma Plc; The Northern Health Science Alliance Ltd (NHSA); the Manchester Academic Health Science Centre (MAHSC); and research specialists Aptus Clinical.
<?UMBRACO_MACRO macroAlias="MediumRectangle" >
The delegation has been backed by KPMG, Bionow, the North of England industry group for life sciences, and the marketing agency Influential.
Neil Murray, CEO of Redx Pharma Plc, the drug development company based at Alderley Park, Cheshire, said: “The UK has a compelling offer to biotech, with one of the strongest and most productive life science sectors in the world and a tax regime that is increasingly favourable for R&D-based businesses.
“The North of England is integral to that offer and produces world class science. The combination of the people and facilities here has already made the region very attractive to international companies. BIO, the largest event of its kind, is the right place for the North to tell its story.”
Rowena Burns, chief executive of Manchester Science Partnerships (MSP), said: “It’s always been the Manchester way to collaborate – we achieve more by working together. Biotech is one of those sectors where academia, industry, the NHS and other organisations and institutions collaborate quite naturally.
“In Manchester we already work in this way and support each other in pitching to global businesses. This approach permeates all sectors of our economy and sends a powerful and positive message to businesses thinking of locating here.”
She added: “This wider North of England initiative at BIO is very welcome. We share a responsibility to speak for the North and to explain the significant competitive advantages our region offers.”